Qingcong Lin

Qingcong Lin

Company: Biocytogen

Job title: CEO


Epigenetic Cell Reprograming to Reduce Target Resistance 9:30 am

• Identifying transcription factors which can inhibit reprograming to lessen tumor resistance • Exploring potential drug combinations which can overcome resistance and prevent tumor growth simultaneously • Discussing the possibilities of artificial transcription factors to epigenetically target gene expressionRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.